Portfolio company
May Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This medical device company develops a minimally invasive ovarian ablation treatment to restore ovulation for women with polycystic ovary syndrome and related infertility.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
UTERINE FIBROID TREATMENT
This medical technology company develops a minimally invasive, uterus-sparing radiofrequency ablation system for women suffering from symptomatic uterine fibroids.
June Livia
This company develops a wearable in-body sensor and mobile application providing continuous reproductive health data for women seeking hormone-free contraception and fertility insights.
vIO Health Tech
The company develops wearable sensors and mobile software for monitoring ovulation and reproductive health to assist women and clinicians with fertility and cycle management.
Solence
This company develops a personalised digital therapeutic application to help women manage and monitor symptoms of polycystic ovary syndrome.
Madorra
This medical device company develops a non-hormonal, non-invasive treatment for vaginal dryness in post-menopausal people and breast cancer survivors.
Afynia
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.
Ablatus Therapeutics
This company develops a bimodal electric tissue ablation medical device to treat tumours and uterine fibroids for surgical patients.
